Genomica
This article was originally published in The Gray Sheet
Executive Summary
Boulder, Colo.-based genomics software developer prices initial public offering of 6.4 mil. shares at $19 each, grossing $122.4 mil. "Our management has broad discretion to allocate the proceeds of the offering," the firm's S-1 prospectus states. CIBC World Markets acted as lead manager for the offering. Dain Rauscher Wessels and Prudential Vector Healthcare Group acted as co-managers. The underwriters have a 30-day over-allotment option to purchase up to 966,000 additional shares. The stock will trade on Nasdaq under the ticker symbol "GNOM"